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A b s t r a c t  
Aqueous solubilization of Ginger Oleoresin (GO) in pseudo self micro emulsifying carrier and its 
influence on ex-vivo intestinal permeation and in-vivo performances was investigated. GO pre-
concentrates was prepared using surfactants, Tween 80, Tween 20 and/or 1:1 mixture with a co-
surfactant propylene glycol at S/Cos ratio 1:1. Aqueous dilutable region of GO in single or mixed 
surfactant systems was located from ternary phase diagram drawn between ternary components 
consisted of surfactant/co-surfactant ratio at 1:1, GO and aqueous phase. Various microstructures 
were characterized across the dilution line using conductometric and rheological method. Three 
formulations were selected across the dilution line from mixed surfactants phase diagram as 
microemulsion area was found to be larger in mixed surfactants over single surfactant based ternary 
system. GO SMEDDS formulations were physically characterized for refractive index, pH, droplet 
size and stability assessment. The permeability of GO in diluted pre-concentrate was determined 
across ex vivo rat intestinal method. Two fold enhancement (p<0.01) in intestinal permeability of GO 
was obtained from SMEDDS formulation  when diluted upto 9.0ml in comparison to under diluted (2 
ml) or over-diluted (25 ml) and control formulation (GO in Tween 80). These findings strongly 
suggested that SMEDDS diluted upto 9ml behave like a pseudo self emulsifying carrier which 
inherently had microemulsion characteristics (droplet size 122nm). Modulation of intestinal 
permeability upon dilution was found closely related with dynamics of microemulsion system. 
Dilution mediated transitions in microstructure of GO SMEDDS was associated with the changes in 
the orientation of surfactant molecules at the oil-water interface of microstructures during 
solubilization of GO. In vivo studies revealed that orally administered GO preconcentrate produced 
1.6 folds enhancement in oral bioavailability of GO  over control. Present study demonstrates that 
intestinal permeability and oral bioavailability can be modulated via exploration of fully dilutable pre-
concentrate GO system which could be a possible carrier to enhance oral bioavailability of GO. 
Keywords: Ginger oleoresin, Dilutable SMEDDS, Mixed surfactant, Ex vivo permeation, 
Bioavailability, Solubilization
Introduction 
Ginger, a folklore medicine and has been used a common 
household remedy in Indian subcontinent since very long time.  
Ginger oleoresin (GO), is a bioactive fraction extracted from 
rhizhome of ginger (Zingiber Officanale Roscoe.) It has potential 
anti-inflammatory, anti oxidant, anti viral, anti colon cancer activity 
due to inhibition of cycloxygenase, 5-lipoxygenase and eicosanoid 
levels.[1-2] Its usefulness in GIT distresses e.g. diarrhea, stomach 
ache has been most widely in therapeutic practice. GO was found 
to effect the xenobiotic/drug metabolism in a concentration-
dependent fashion and modulate the metabolizing enzymes 
(CYP2C19). Recently, GO interaction with p-glycoproteins 
substrates has increased its the interest in pharmaceutical 
formulations as it affects the pharmacokinetics of low bioavailaible 
drugs. [3] 
 
The major impediment in formulations development of GO is its 
poor aqueous solubility which limits its oral bioavailability and 
pharmaceutical usage. [4]  Major active components known for 
pungency are present in GO are series of gingerols specifically 6-
gingerol and dehydrated gingerols. Following oral administration of 
GO (300mg/kg dose) in rats, 6-gingerol is the most abundantly 
present in GO, produces the plasma concentration of 4.23 mcg/ml 
owing to high tissue binding and high intestinal metabolism. [5] 
Poor solubilization of drug substance is the major issue in 
development of pharmaceutical formulations. To overcome such 
characteristics, Lipid based self micro emulsifying delivery systems 
(SMEDDS) have emerged as drug carrier system gave promising 
results by improving the solubilization characteristics of drug and 
inturn bioavailability enhancement. of poorly soluble drugs  e.g. 
carvidilol, itraconazole as well as natural products of therapeutic 
importance like curcumin and carotenoid lutein.[6-9] 
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SMEDDS has been shown to play an important role in modulating 
the ADME of poorly bioavailable drugs which has limited aqueous 
solubility. Double surfactant based SMEDDS formulations has 
been reported to modulate the intestinal permeation 
characteristics, inhibiting intestinal efflux pumps, p-glycoproteins 
inhibition, as well as stabilization of drug in gastrointestinal regions 
to increase the oral bioavailability of drugs [10-11]. In an example, 
tocopheryl polyethylene glycol succinate (TPGS) and Cremophor 
EL40 were used in double surfactants in SMEDDS, has been found 
to modulate the intestinal permeability of tacrolimus. The possible 
explaination to this finding was the effect of selected surfactants on 
p glycoprotein inhibition. [12]. Similarly, it has been investigated 
that intestinal CYP3A activity in rat was found to be significantly 
inhibited by PEG-400. [13] 
In an optimized SMEDDS formulation prepared using either single 
or mixed surfactants (tween 80) has been reported  to loosen up 
intracellular tight junctions of enterocytes which significantly 
increases the permeability of drug to several times, and thereby 
enhance the absorption of gancyclovir [14-15] In an another report, 
Tweens was found to inhibit the p-glycoproteins mediated drug 
efflux and increased the paracellular absorption of poorly 
permeable drug to many folds,  e.g. carmazepine permeability was 
altered using tween based dilutable formulation. [16] Tween 80 
significantly increased absorption by changing transport balance 
between absorptive transport and secretive transport of rhodamine 
123 and digoxin. [17]  
It is likely that Tween based dilutable SMEDDS formations of GO 
would be as an alternative carriers in the drug delivery of naturally 
occurring compounds e.g.  gingerols as GO has poor  aqueous 
solubility characteristics. On these basis, it has been proposed that 
the formulated system would facilitate the aqueous solubilization of 
GO, altered the intestinal permeability and may show interactions 
with drug transporters.  
The aim of present investigation is (i) to assess the feasibility in 
formation of self micro emulsifying dilutable formulation of GO and 
its physical characterization (ii) to investigate the in vivo/ex vivo 
performances of self emulsifying diluted/ preconcentrate of GO and 
its interrelationship with microemulsion microstructures. 
Material and Methods 
GO was purchased from Synthite Chemical, Kerala, India 
(containing 30% w/w of total gingerols, devoid of any heavy metals, 
as analyzed by ICPMS, data not shown), Tween 80 
(polyoxyethylene sorbitol mono-oleate) and Tween 20 
(polyoxyethylene sorbitol mono-laurate) was procured from Sigma.  
Analytical grade propylene glycol (PG) was obtained from Merck, 
India. All other reagents and buffer solutions used in different 
studies were of analytical grade. Bi-distilled followed deionized 
water was used in all experiments and was prepared in department 
laboratory. 
Construction of phase diagram and formulations of GO-
SMEDDS 
Pseudo-ternary phase diagram was dawn from oil phase consisting 
of GO, (specific gravity 1.023 gm/cm3), surfactant and co-
surfactant mixture at surfactant/cosurfactant mass ratio (km=1.0) 
and water by aqueous titration method. Surfactants either single or 
mixed consisted of Tween80 and Tween20 (1:0, 1:1, 0:1; HLB 16, 
16.5 and 17 respectively) whereas propylene glycol (specific 
gravity=1.036gm/cm3) was taken as co-surfactant.  The 
temperature was maintained by RE 320 THERMOSTAT controlled 
at 30μ0.5 ÀC. Three GO SMEDDS formulations was prepared 
across the dilution line and characterized  
Characterization of GO-SMEDDS 
Conductivity measurement 
The electrical conductance (Ĕ) was measured using DELUXE 
conductivity meter (MS Electronics India Pvt Ltd, Harayana, India) 
operating at 50Hz. The temperature was kept at 30μ0.5ĈC and 
maintained by thermostatic controlled. Conductance of 
microemulsion was measured by taking preconcentrate mix of oil 
and surfactant/co surfactant and titrated with aqueous phase. 
Viscosity measurement 
Rheological studies of samples were performed on Brookfield R/S 
(Model ps-p) cone and plate viscometer (Brookfield Engineering 
Laboratories, Inc, Middleboro, MA; attached spindle # 50.3250; 
type C25-2 at shearing rates (1/s) values 25-400. The software 
used for the calculations was Rheocal V2.8. Apparent viscosities 
(eta value) were measured and an average of ten readings at the 
interval of ten seconds with total run time of 100 seconds was 
recorded at 30μ 0.5ÀC. Distance between the cone and plate was 
kept 0.01mm with cone angle 1Ĉ 
Analysis of globule size and surface charge  
The globule size was determined using a photon correlation 
spectrometer (Zetasizer 1000 HAS, Malvern Instruments, 
Worcestershire, UK). Light scattering was monitored at 25ĈC at a 
90Ĉ angle. Average particle diameter (dm), polydispersity index (p–) 
and zeta potentials were recorded and shown in Table 3. The p– 
reflects the uniformity of droplet diameter and can be used to 
depict the size distribution in the droplets population. The 
measurement time was 2 min and each run underwent 10 sub 
runs. The preconcentrate was dispersed with different 
concentration of water for which 1.0 ml aliquot was withdrawn and 
added into a sample cell for globule size measurement. Each size 
value reported was the average of at least three independent 
measurements. Zeta potential was measured simultaneously on 
the same diluted sample using the same equipment and operating 
conditions as measured in droplet size.  
pH 
pH of the samples  was determined at room temperature by 
SIMTRONIC digital pH meter India ltd, model  SE-962P. 
Specific gravity   
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Specific gravity of samples was measured with calibrated 
BOROSIL specific gravity bottles at 30μ 0.5 ÀC. For each 
measurement, the specific gravity bottle was washed, rinsed and 
vacuum dried. The average limit of error in specific gravity 
measurement was μ 2%. 
Refractive Index 
Refractive index of samples was determined by using ABBE type 
refractometer at 30μ 0.5 ÀC. 
Stability Assessment of GO-SMEDDS 
Centrifugation  
Mechanical stability of formulations was determined by placing the 
sample in a centrifuge (TARSON) operated at 3000 rpm for 30mins 
and visual inspection of any physical in-stabilities in sample was 
observed.   
Thermal testing 
Thermal stability of the samples was assessed by placing them at 
30μ 0.5ĈC maintained in an oven for six months. The samples were 
visually inspected for appearance, phase separation, loss of 
volume due to evaporation at the intervals of 1, 2, 3 and six 
months.  
Permeability & Bioavailability assessment of GO-
SMEDDS 
Ex vivo Intestinal permeability  
Intestinal permeability of GO (quantified as 6-gingerol) was 
determined from GO pre-concentrate and its control formulations 
using ex vivo intestinal perfusion method. [34,35]. Approval to carry 
out ex vivo intestinal permeation on rat ileum was taken from 
Institution Animal Ethical Committee, of Jamia Hamdard, New 
Delhi, India. These studies were followed prior approval under 
CPSEA guidelines and confirms to national guidelines on the care 
and use of laboratory animals (protocol proposal No: 566/2009). 
Male wistar rats weighing 250μ20 g were provided by Jamia 
Hamdard, New Delhi, India. The animals were housed in standard 
conditions of temperature (25μ2 ĈC), in 12/12 h light and dark 
cycles and fed with standard pellet diet and water ad libitum. 
Animal handling was followed in accordance to Good Laboratory 
Practice (GLP).  
Rats were kept under fasting condition prior 12 h before 
experiment but allowed to have free access of water. Rats were 
sacrificed by vertebral dislocation method and entire 
gastrointestinal segment from ileum was surgically removed.   
Isolated ileum (5.0cm) was washed and thoroughly rinsed and 
immediately immersed in phosphate buffer pH 7.4 chamber [29, 
30], besides aspiration of carbogen gas was also maintained so 
that tissue viability remains till the end of experiment. 
Ileum sac was filled with 1.0ml of sample and ligated at both ends. 
The receiver chamber was filled with phosphate buffer (pH-7.4) 
(50.0 ml volume) and stirred with a magnetic rotor at a speed of 
100 rpm in a hot air oven maintained at a temperature of 37μ0.5ÀC.  
Samples (0.5 ml) were withdrawn at pre-determined intervals (0, 
0.1, 0.2, 0.4, 0.8, 1.0 h) and filtered through 0.45 øm membrane 
filter and analyzed for GO content. Analytical methodology of GO 
consisted of HPLC method where 6-gingerol was determined at 
λmax of 290.0 nm by reproducing official compendia method as 
given in Indian Pharmacocpoeia (IP) 2010 modified as per system 
suitability[18]. The apparent permeability (Papp) of GO was 
calculated using following equation.  
P(app) = dQ/dt * (1/AC0) 
where dQ/dt is the slope of line determined from graphical plot 
drawn between cumulated drug permeated vs. time and A is the 
effective area of the ileum portion taken under study, C0 is the 
initial amount of oleoresin filled in the length of ileum sac.  
Pharmacokinetic study 
Male wistar rats (250μ20g) were taken, provided by the Central 
Animal House, Jamia Hamdard, New Delhi, India. The rat 
conditions were maintained and described previously under ex-vivo 
permeation section. The rats were kept intentionally deprived of 
food but given free access to water 12 h before the experiment to 
begin.  
GO SMEDDS formulation was orally administrated in undiluted 
form and control group was administered GO in Tween 80 at the 
dose level of 300 mg/kg of body weight. Each formulation was 
administered by oral gavage to rats using an animal feeding 
needle. Blood samples (0.75 ml) were collected through alternate 
retro orbital plexus at the intervals of 0, 15, 30, 45, 60, 120, 240 
and 480 min after oral administration (n=6 for each time point) into 
heparinized microcentrifuge tubes.  
Plasma was separated from collected blood samples followed 
centrifugation at 13,000 rpm at 20 ĈC for 20 min, and were stored in 
minus 80 ĈC deep freezer before analyzing. The samples were 
analyzed by reproducing LCMS-MS method as reported by Wang 
et al, 2009 [12] modified as per system suitability validated prior 
applying test samples. 
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Table-1 Composition of GO pre-concentrate, diluted GO-SMEDDS and control formulations from mixed surfactant system  
  
      S/CoS (wt%)              GO (%wt)             Water (%wt)         Type 
 
           GOM0  97.5       2.5                  -      reverse micelle 
              GOM2          94                   1.25                        4.7        water-in-oil  
              GOM9          81                   0.5                       18        oil-in-water  
GOM25          68      0.2             27                 oil-in-water  
GOOtwn  -      05              -   
GOOpyl  -      05              -   
 
GOM0=GO undiluted pre-concentrate; GOM2=GO microemulsion diluted to 2.0ml; GOM9= GO microemulsion diluted to 9.0ml; GOM25= GO coarse emulsion 
diluted to 25.0ml; GOOtwn= GO in tween 80; GOOpyl= GO in propylene glycol.   
 
Table-2 Physical characterization of GO-SMEDDS formulations  
 
    S. gravity pH  Ref. index    Droplet        Viscosity  Conductivity 
                  (gm/cm3)                                                  size (nm)        (mPas)  (øS/cm)             
 
GOM0          1.113μ0.01   -             1.324  -        40.42       0.946 
GOM2    1.095μ0.01  7.05μ0.02    1.125            22        92.45      12.14 
GOM9    1.045μ0.02  6.49μ0.03           1.355  122        42.84       614.2 
GOM25    1.010μ0.03  6.41μ0.02           1.224   a        55.31      1281.1 
GOOtwn    1.012μ0.01  6.23μ0.02           1.230  -        49.85       941.6 
GOOpyl    1.034μ0.02  6.12μ0.03           1.235  -        53.76       843.2 
 
*value determined at 400 sec-1 shearing rate a=formation of coarse emulsion; Data represent mean μ standard deviation (sd)   
 
Table-3 Evaluation of short term thermal and mechanical stability of GO-SMEDDS formulations   
 
    Centrifugationa      Thermal stabilityb        Conductivity       Viscosity          Droplet size      
                    (3000 rpm)                (40 ĈC)                  (øS/cm)                 (mPas)                  (nm)    
 
GOMo         stable   stable       1.024μ1.21          41.34μ1.23   -  
GOM2 stable   stable         12.52μ2.22          93.56μ2.34   22 
GOM9 stable   unstable       625.1μ 3.35          44.34 μ3.91  135 
GOM25 unstable   unstable        1250.4μ5.67         51.91μ5.67    c 
GOOtwn       stable   stable       929.2μ5.67           50.55μ2.48   - 
GOOpyl  stable   stable        845.7μ7.56         55.21μ3.54   - 
 
Data represent mean μ standard deviation (SD), n=3;  a stability assessed for a hour cycle b for six month storage c formation of coarse emulsion 
 
Results and Discussion 
In order to prepare GO SMEDDS, ternary components selected 
were GO, propylene glycol, and polyoxyethylene sorbitan mono-
laurate (Tween-20) or polyoxyethylene sorbitan mono-oleate 
(Tween 80) or its mixture at 1:1 as oil phase, co-surfactant and 
surfactant/s respectively at surfactant/ cosurfactant ratio (Smix 
ratio; 1:1). Single surfactant based phase diagrams was 
represented from Fig 1a and 1b while phase diagram from mixed 
surfactant is shown in Fig 1c. Existence of isotropic regions from 
single or mixed surfactant system to be required for the formulation 
of GO SMEDDS was investigated in this paper.  
 
Ternary system components selected in formulation designing of 
GO-SMEDDS are safe, biocompatible, non volatile with 
appreciable IEG limits and have generally regarded as safe 
(GRAS) status. The surfactants chosen in GO SMEDDS were 
mutual miscibile with GO and the selected co-surfactant. Tween 80 
(HLB = 15) and Tween 20 (HLB = 18) are non-ionic surfactants 
employed in topical, oral and parenteral formulations. [19-21] 
Propylene glycol, a co-surfactant/cosolvent has good solublization 
capacity for lipophilic as well as hydrophilic drugs and exhibits 
mutual misicibility with wide variety of surfactant and oils 
components.  
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A possible explanation for the identification of dilutable region in 
phase diagram prepared from mixed surfactants over single 
surfactant was to increase the possibility to find more 
microemulsion region which may produce dilutable GO SMEDDS 
on aqueous phase dilution. Moreover, double surfactant has been 
shown to have excellent solubililization potential than single 
surfactant. More isotropic region with increased micro-emulsion 
area has been seen from mixed surfactants based ternary 
diagrams. Surfactant/cosurfactant mass ratio (km=1.0) was kept at 
unity. The role of cosurfactant was not produced much significant 
difference in the microemulsion phase region at higher surfactant 
proportions (data not shown).  
Surfactants were selected on the basis of different hydrophilic 
lipophilic balance (HLB) values to form GO SMEDDS.  Single 
surfactant did not produce significant affect on the microemulsion 
area or aqueous dilutable region. While using higher surfactants 
ratios at 2:1 and 1:2, did not provide any increase in isotropic 
region of microemulsion. It revealed that GO has poor solubilization 
characteristics in cosolvents also. Moreover, feasibility of larger 
higher surfactant ratios would result in poor rheological 
characteristics which may result in difficulty in aqueous dilution. 
The extent of aqueous dilutable region in isotropic system was 
confined upto 9.0ml and beyond that region this system was 
broken down as GO SMEDDS turned into dull brown, eventually 
formation of coarse emulsion of GO took place. Therefore, dilution 
phenomenon may be explained in terms of transitioning from 
microstructures when GO SMEDDS was converted into 
microemulsions.  Formation of GO SMEDDS was found to depend 
upon the limited dilution capacity (upto 9ml) which may be 
associated with existence of internal microstructures when GO 
SMEDDS was converted into microemulsion upon mixing with 
water (data not shown). Effect of dilution phenomenon on 
microstructures can be analogically described as the formation of 
pseudo SMEDDS when diluted upto 9.0ml where internalized GO 
in dispersed phase nanodroplets was partially stable. Further 
addition of water make pronounced changes in internal structure of 
nano-size dispersion leads to transformation into coarse emulsion. 
Phase diagram 
Poor misicibility of GO in oils, co-solvents is the major hindrance in 
the formulation of its conventional dosage forms. Ternary 
components was selected on the basis of miscibility of GO and 
found to be miscibile with propylene glycol, and mixture (1:1) of 
polyoxyethylene sorbitan-monooleate, polyoxyethylene sorbitan 
mono-laurate at S/Cos ratio 1.0. To identify the microemulsion 
region and to delineate it from coarse emulsion and liquid 
crystalline regions, pseudo ternary phase diagram was plotted.  
Phase diagrams from single vs. mixed surfactant based systems 
are represented in Fig 1. The existence of two distinct regions was 
appeared in single or mixed surfactants system as revealed from 
the phase boundary drawn in phase diagram.  Microemulsion 
region are represented from single phase, isotropic area in the 
phase diagram where oil, water and surfactant/co-surfactants 
components spontaneously formed at room temperature. It is 
noteworthy to mention the area of microemulsion region from 
mixed surfactant system is more pronounced in comparison to 
single surfactants.  The reason for selection of mixed surfactant 
system is obvious as it has more dilutable region in comparison to 
either tween 20 or tween 80. No difference in microemulsion area 
of ternary phase diagram drawn using tween 80 or tween 20 was 
observed.  Despite the microemulsion areas was also identified at 
surfactants/cosurfactant ratios at 2:1 and 1:2 levels.  Higher ratios 
of Smix in microemulsion produced more viscous system which 
delayed mixing with water and the formation of thick gels resulted. 
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Figure 1 Pseudo ternary diagrams drawn at Smix 1:1 at different type of surfactant a) mixture of Tween80-Tween20 (1:1); b) Tween 20; c) 
Tween 80 alone. Ternary diagram shows phase boundary to delineate the microemulsion region (one phase, transparent region) from coarse 
(two phase, shaded region).  Aqueous dilution line was drawn across microemulsion region to characterize microstructures domains.   
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Figure 2: (a) Effect of aqueous dilution on the conductivity of ginger oleoresin pre-concentrate (GO 5% and S/CoS 95%) transformation from 
reverse micelle to coarse emulsion via formation of different microemulsion structures in the course of dilution.  (b) Plot of logarithm transformed 
conductivity values vs. addition of aqueous phase volume showing percolation phenomenon. 
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Conductivity measurement 
Conductance measurement is a precise characterization tool 
extensively used in dispersion systems and more specifically to 
quantifying the changes observed at microstructure level brought 
out by the addition of aqueous phase. The results obtained from 
electrical conductance (Ĕ) also described the inherent 
characteristics of phase behavior during formation of 
microemulsion droplets from pre-concentrates/GO-SMEDDS.  
Microstructural transition from oil continuous to water continuous 
microemulsion systems were characterized from conductivity 
changes and percolation appeared with aqueous phase dilutions.  
In the present context, percolation phenomenon was also observed 
in GO SMEDDS during aqueous phase dilution as represented in 
figure 2.  
The linear plot was drawn between conductance and the volume of 
aqueous phase added to the GO preconcentrate was represented 
in fig.2 (a). It showed that initially very small rise in conductance 
values was observed when its composition was represented from 
oil/surfactant/co-surfactant mixture containing 95% of S/CoS, 5% of 
oil phase. Electrical conductance of preconcentrate was changed 
slowly along the line OX but gradually increased with dilution 
represented from XZ line. As depicted in the fig 2a, linear 
conductivity was plotted with volume of aqueous phase in GO 
SMEDDS  strongly suggest the formation of oil continuous system 
when preconcentrate of GO was diluted upto 2.0ml since no sharp 
increase in conductance of preconcentrate was observed. It 
suggests that undiluted preconcentrate existed in the form of 
reverse miceller mixture consisted of GO and Smix, which upon 
aqueous phase dilution   internalized the water molecules in its 
core to form w/o droplets. Formation of w/o microemulsion was 
continued till the system was diluted upto 2.0ml.  
Much variation in conductance values has been observed when the 
volume of aqueous phase exceeds above 2.0ml. Conductance of 
GO SMEDDS was sharply raised to higher values with very little 
quantity of aqueous phase added.  This incremental change in 
conductivity of GO SMEDDS was continued upto 9.0 ml of water 
addition and the system was appeared to be fully transparent.  The 
first sign when GO integrity in SMEDDS changed in visual 
appearance of microemulsion was observed when volume of 
aqueous phase exceeds to 9.0ml Beyond 9.0ml the microemulsion 
formed from SMEDDS turned into dull in appearance and lost into 
brilliance.  
Precise composition in the microemulsion system of different w/o, 
bicontinous and o/w system was revealed and further on 
extrapolation, it delineated the phase boundary between micro 
emulsion and coarse emulsion. 
Log conductance value of GO SMEDDS vs. volume of aqueous 
phase was plotted in fig 2(b). Graphical representation showed the 
existence of three distinct regions as appeared from percolation 
that the formation of w/o droplets took place from reverse micellar 
solution and on further addition of water, bi-continuous structures 
were formed upto 6.0ml which finally converted into o/w structures 
upto 9.0ml. No orientation of internal structures has been observed 
beyond this dilution point further.  No decreasing pattern in the 
conductivity had been observed when o/w microstructure was 
turned into coarse emulsion. It showed that sharp incremental 
change in conductance values with water addition represents a 
transitioning in internal structure of microemulsion. When the 
microstructure system was broken down at the ends, mixed 
surfactants of GO SMEDDS could not retain the GO compound 
into microstructure and allowed the GO to escape into aqueous 
phase.   
 The conductivity of diluted SMEDDS formulations containing 
varied amount of oil and surfactant/co-surfactant were measured 
and their composition is shown in table-1.  
Viscosity measurement  
Rheological characterization has been employed in colloidal 
dispersion systems, transition between the internal structures or 
isotropic or mesophase existed in ternary phase diagram.   
The viscosity of diluted GO SMEDDS was characterized along the 
dilution line at various shearing rates (1/s= 25, 50, 100, 200, 300 
and 400 rpm) and represented in figure 3. Viscosity of GO 
SMEDDS was changed with addition of volume of aqueous phase 
to the physical mixture consisted of GO (3%) and Smix (97%). 
At the starting point, little variation in the viscosity of system was 
observed upto 2.0ml with addition of very small quantity of water.  
On further addition of water to 6ml, viscosity has been increased 
and reached its highest level at water phase added to 9.0 ml.  
Viscosity then showed declining trend on further addition of water.  
It is well acknowledged that viscosity of dispersed phase was 
gradually increased upon aqueous phase dilution till formation of 
swollen micelles.  These results indicated that weak entanglement 
between oil and water phases observed at w/o microemulsion 
system. At intermediate stage, water and oil phases obstruct 
mutually consequently increases the viscosity of the system.  
Dynamic viscosity of GO SMEDDS was higher when more 
entanglements between oil and water phases existed in presence 
of water molecules. Entanglements among the structures are 
probably due to the relative position of surfactant molecules at GO-
water interface.    
Oil continuous nanostructure was formed as a result of transition in 
microstructure from reverse miceller mixture consisted of S/CoS 
and GO diluted with aqueous phase. Therefore the viscosities of 
each microstructure varied with aqueous phase content.  
Interpretation of viscosity behavior was almost comparable to that 
of electrical conductance measure of GO SMEDDS.  
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Figure  3: Effect of aqueous dilution on the dynamic viscosity of ginger oleoresin pre-concentrate (GO 5% and S/CoS 95%) measured at 
shearing rate (25-400 sec-1) of mixed surfactant system. 
 
Formulation characterization 
 
Figure 4: FTIR spectra of the GO SMEDDS diluted with varying proportion of aqueous phase and spectrum of GO. a, b, c, d indicated 0, 
0.5, 2, 9ml addition of water to GO SMEDDS.  
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Table-4 FTIR characterization of GO-SMEDDS formulations  
 
     OH stretching  CH stretching, Intensity   Ester Linkage, Intensity       
     (3000-3600 cm-1)     (2800- 3000 cm-1)          (1200-1300 cm-1)             
 
GOM0        3410    2919, 41   1295, 72 
GOM0.5     3412    2920, 23   1296, 63 
GOM2     3414    2920, 52   1296, 75 
GOM9     3417    2920, 45    1296, 73 
GOM25    3437    2924, 85   1281,   - 
GO    3433    2929, 72     - 
 
Figure 4 shows the IR spectra of GO SMEDDS and GO and their 
characteristic group frequencies are given in the table-4. In reverse 
micelle, GOM 0.5, GOM2 and GOM9 systems, group frequency 
representing -OH group were slightly changed from 3410 to 3415 
cm-1 regions as well absorption intensities. Slight change in group 
frequencies in GO SMEDDS with addition of water to reverse 
micelles indicates relatively strong interaction between polar head 
groups of surfactants with water molecules. This interaction was 
weakened with addition of water upto 9.0ml of water but GO 
molecules were strongly bound in the lipophilic side chain of the 
surfactant. Beyond 9.0ml  or at higher water content, polar head 
group of surfactant molecules has least affinity towards water 
molecules also it freed the GO molecules from its core as its  group 
frequency matched with pure GO. 
 
 
 
 
Figure 5 GO SMEDDS droplet size and droplet size distribution changed under the effect of aqueous dilution. A) GO SMEDDS diluted to 2.0ml 
aqueous phase volume; B) diluted to 9.0ml with aqueous phase volume. 
Droplet size measurement & polydispersity index 
Droplet size and its distribution of GO-SMEDDS diluted upto 9.0ml 
was shown in the figure 4 and again it was further confirmed by 
droplet size measurement.  Droplet size and polydispersity of 
different formulations diluted from 2.0ml to 9.0ml were shown in 
figure 4 (a) and (b) respectively. GO droplet size was changed from 
22 to 122nm when volume of aqueous phase was increased from 
2.0ml to 9.0ml in the SMEDDS.   These results obtained from 
droplet size measurement confirmed that addition of aqueous 
phase volume to pre-concentrate mixture increases the size of 
microemulsion droplets due to transformation of reverse micelle to 
swollen reverse micelles. [22] It also suggested that the structural 
variation initiated when surfactant/co surfactant mixture with GO 
mixed with aqueous phase, droplet size of diluted preconcentrate 
formulation of GO was in nano size range with low polydispersity 
index. As the formulation composed of non ionic surfactants, its 
zeta potential values remained unaffected with addition of water. 
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GO SMEDDS found to be safe as its pH values were in neutral 
range between 6.8 to 7.2. Ternary components chosen are lipidic / 
non ionic in nature and could not be effected with the pH. Other 
characteristics of GO SMEDDS like specific gravity and refractive 
index were shown in the table -2. 
Ex vivo intestinal permeation  
Ex vivo permeation from GO-SMEDDS as well as its control 
formulations were determined using rat intestinal perfusion method. 
Calculated Peff values of GO from GO SMEDDS diluted with 
aqueous phase and controlled groups were represented in figure 5. 
From the permeation study, it has been demonstrated that dilution 
played a significant role in intestinal permeation of GO from 
undiluted GO-SMEDDS. No significant difference in GO 
permeability was observed from GO-SMEDDS or from GO 
formulation control. Experimental data suggests that no significant 
difference in GO permeability was observed from undiluted or over 
diluted GO-SMEDDS. Statistical difference in GO permeability was 
observed from GO-SMEDDS diluted upto 9.0 ml. (p<0.01)  
The observation of permeability enhancement from GO SMEDDS 
was found to be closely associated with dilution effect on 
SMEDDS. During dilution,of surfactant/cosurfactant and oil premix, 
various nanostructures was formed when it was diluted with 
water.[23] It has been proposed that existence of microstructures 
altered the nature of dispersed phase globules with aqueous 
dilution.  In the present case, when the preconcentrate system was 
over diluted, GO in dispersed phase occupy large droplet size, 
possibly in the coarse emulsion range and limit the solubilization of 
GO in SMEDDS. Lesser diluted SMEDDS transformed from of 
reverse micelles to w/o.  Eventually in both the cases systems 
could not give significant difference in GO permeation. These 
results were in accordance with the results obtained from 
conductivity, viscosity and droplet size studies that nature of 
globules and globule size distribution of GO in SMEDDS was 
significantly varied with dilution. Incorporate amount of surfactant 
present in the GO SMEDDS may be regarded as another 
contributing factor for permeability enhancement.  
Tween 80 alone has been shown to modify the permeation 
characteristics of compounds across intestinal membrane. [24], It is 
also observed that the control formulations comprised of tween 80, 
and PG did not show significant differences in intestinal 
permeability of GO. This phenomenon could be attributed to poor 
solubilization of GO in these vehicles, however its solubilization 
was improved in GO SMEDDS.  
 
 
Figure 6: Effect of aqueous phase dilution on the intestinal permeability of GO (as quantified from 6-gingerol). Permeability of GO was also 
determined from selected ternary components like tween80 and PG.  Data represent mean μ standard deviation (sd) n=6, Data was 
analyzed at significance level (p<0.01) using one way ANOVA with Dunnett test.  
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Pharmacokinetics studies 
Table 5: Pharmacokinetic parameters of GO after oral administration of GO SMEDDS and control formulation  
      
                   GO CONTROL             GO SMEDDS    
 
AUC(0-8hrs) (μg/ml hr)  1.46μ0.24               2.37*μ0.21 
MRT(0-8hrs) (hr)   1.98μ0.02                   2.01μ 0.02 
Cmax (øg/ml)   0.64μ0.03        1.55μ0.01 
Tmax (min)    0.50μ0.01        0.39μ0.02 
 
Data represent mean μ standard deviation (sd)  * p <0.01 by student t-test.  
  
Figure 7: Mean plasma conc. vs. time profile of GO followed oral administration of SMEDDS vs. Control (GO in tween80 base).  GO was 
orally administered at the dose of 300mg/kg in SMEDDS to Wistar rats. Data represent mean μ standard deviation (sd), n=6. 
 
Pharmacokinetics studies 
GO SMEDDS in preconcentrate form was orally administered to 
rats with minimal quantity of water (2.0ml). The purpose behind this 
assumption was the possibility of GO SMEDDS in pseudo self 
microemulsifible formulation may turned into coarse emulsion in 
contact with gastrointestinal secretions. Absorption profile of GO 
from control as well as SMEDDS formulation was shown from 
plasma concentration vs. time profile in the figure 7. 
Pharmacokinetic parameters were computed from absorption data 
as described in Section 2.8 and tabulated in Table 5.  The results 
from in vivo study showed that the AUC(0ă8 hrs) and Cmax of GO 
(quantified by 6-gingerol as most abundantly present in the GO) 
from GO SMEDDS formulation were increased by 1.6-fold and 2.4-
fold respectively in comparison to the control group (p<0.01). 6-
gingerol was rapidly absorbed from GO SMEDDS with a tmax of 30 
mins while its control has same time point.  No lag time during 
absorption of GO from entire region of gastro intestinal tract was 
observed.  
Several contributing factors may be associated with bioavailability 
enhancement of GO formulated with SMEDDS.  Aqueous 
dispersion of the active components from GO in the  
gastrointestinal environment being the rate-limiting step in GO 
absorption. GO-SMEDDS dispersed spontaneously into 
microemulsion when comes in contact with gastric secretions. An 
ultra fine dispersion of nano droplet size may be formed which 
facilitate the rapid and extensive absorption of GO due to 
availability of large surface area. [25] Followed by gastric emptying, 
microemulsion formed in stomach region undergoes dilution in 
intestinal region and eventually turned into coarse emulsion upon 
mixing with intestinal fluids which increases GO droplet size.  
Breakdown of internal microstructure domain of microemulsion 
from SMEDDS, decreased the oral absorption of GO, which may 
either took place from lymphatic transport or through transcellular 
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pathways. In addition, modulation of intestinal permeation of GO 
formulated in SMEDDS using mixed surfactants could be 
corroborated with bioavailability enhancement as observed in the 
ex vivo intestinal permeation studies. [26-27]. It was seen from the 
absorption profile that following absorption phase immediate fall in 
plasma concentration of GO took place where GO was 
metabolized by intestinal microsomal enzymes. [28]   
Conclusions 
In the present investigation, the mechanistic approach to elucidate 
the physical behaviour of GO SMEDDS and its influence on 
preclinical bio-interfaces was explored. Dilution phenomenon was 
observed in mixed surfactant based GO SMEDDS and existence of 
different microstructures was located using rheology, 
conductometry and infra red spectroscopy. Different 
microstructures were taken as base formulations of ginger 
oleoresin (GO SMEDDS) which significantly modulated and 
enhanced the intestinal permeability and absorption of GO. 
However, over diluted GO SMEDDS compromised the 
microstructural integrity and hence challenged biopharmaceutical 
attributes of GO. Hence, it has been shown that the aqueous 
dilutability of a pseudo carrier system of GO hampered aqueous 
solubilization of GO in SMEDDS. Extent of absorption and 
improved solubilization of GO could be increased many folds to the 
current 1.6 times enhancement of GO if it was made fully dilutable 
and remained in range of nano droplet size.  
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